Skip to main content
The Canadian Collaborative for Childhood Cannabinoid Therapeutics

The Canadian Collaborative for Childhood Cannabinoid Therapeutics (2)

"From anecdote, to evidence. Our mission is to conduct and share high-quality research on cannabis used for medical purposes in children informed by patients, parents, healthcare practitioners, policy makers, and the scientific community." 

 
Why is cannabis research so much harder than researching other medicines? Lauren Kelly PhD is an Associate Professor at the University of Manitoba, Cannabis researcher and Trialist, CCIC President, and CMCN Co-Lead, she joins Reefer MEDness to explain why cannabis clinical trials face unique barriers in Canada. Learn how Health Canada regulations, GMP vs GPP standards, product consistency challenges, and gaps in the Cannabis Act affect research, patient care, and evidence generation. Discover why researchers often can't study the same cannabis products patients actually use, how clinical trials begin from real-world observations, and what Canada can do to become a global leader in cannabis science. Listen now to understand the hidden challenges behind cannabis research and the future of evidence-based medical cannabis.

Can medical cannabis help children—and what does the evidence actually show? Pediatric pharmacologist, Dr. Lauren Kelly, joins Trevor and Kirk to discuss medical cannabis in children. This wide ranging conversation includes discussion about epilepsy, autism, pediatric oncology, and the unique challenges of studying cannabinoids during development. Learn what researchers know about CBD, THC & kids, why evidence remains relatively limited, and how stigma, policy, and education continue to affect patient care. Listen now for an evidence-based discussion on pediatric cannabis research, safety, and the future of cannabinoid medicine for children.